106 related articles for article (PubMed ID: 623673)
21. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
[TBL] [Abstract][Full Text] [Related]
22. Approaches to overcome in vivo anti-cancer drug resistance.
Rustum YM; Radel S; Campbell J; Mayhew E
Prog Clin Biol Res; 1986; 223():187-202. PubMed ID: 3492716
[TBL] [Abstract][Full Text] [Related]
23. Effects of 2-deoxy-D-glucose and 3 deazauridine individually and in combination on the replication of Japanese B encephalitis virus.
Woodman DR; Williams JC
Antimicrob Agents Chemother; 1977 Mar; 11(3):475-81. PubMed ID: 856001
[TBL] [Abstract][Full Text] [Related]
24. The structure of nucleosides in relation to their biological and and biochemical activity: a summary.
Bloch A
Ann N Y Acad Sci; 1975 Aug; 255():576-96. PubMed ID: 53023
[No Abstract] [Full Text] [Related]
25. Phosphorylation of nucleosides catalyzed by a mammalian enzyme other than uridine-cytidine kinase.
Ahmed NK; Germain GS; Welch AD; Paterson AR; Paran JH; Yang S
Biochem Biophys Res Commun; 1980 Jul; 95(1):440-5. PubMed ID: 6158318
[No Abstract] [Full Text] [Related]
26. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
27. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL
Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649
[TBL] [Abstract][Full Text] [Related]
28. Intracellular nucleotide pools and their significance in antimetabolite therapy.
Harrap KR; Renshaw J
Antibiot Chemother (1971); 1980; 28():68-77. PubMed ID: 6998365
[TBL] [Abstract][Full Text] [Related]
29. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Lauzon GJ; Paran JH; Paterson AR
Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.
Han T; Fernandez M; Chou TC; Agarwal RP
J Cancer Res Clin Oncol; 2005 Sep; 131(9):609-16. PubMed ID: 16044347
[TBL] [Abstract][Full Text] [Related]
31. Antiviral and cytotoxicity evaluation of 3-nitro-3-deazauridine.
Allen LB; Teepe AG; Kehoe MJ; Holland CS; McNamara DJ; Cook PD
Antiviral Res; 1989 Dec; 12(5-6):259-67. PubMed ID: 2634363
[TBL] [Abstract][Full Text] [Related]
32. Synthetic studies on 3-deazauridine derivatives.
Kaneko M; Robins MJ
Nucleic Acids Symp Ser; 1982; (11):49-52. PubMed ID: 7183971
[No Abstract] [Full Text] [Related]
33. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Grant S; Cadman E
Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
[TBL] [Abstract][Full Text] [Related]
34. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; Veselý J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
Chabot GG; Bouchard J; Momparler RL
Biochem Pharmacol; 1983 Apr; 32(7):1327-8. PubMed ID: 6189497
[No Abstract] [Full Text] [Related]
36. Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine.
Gao WY; Johns DG; Mitsuya H
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):371-7. PubMed ID: 10772721
[TBL] [Abstract][Full Text] [Related]
37. The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma.
van Kuilenburg AB; Meinsma R
Biochim Biophys Acta; 2016 Sep; 1862(9):1504-12. PubMed ID: 27239701
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial and pharmacokinetics of a daily x 5 schedule of 3-deazauridine.
Creaven PJ; Priore RL; Mittelman A; Bruno S; Henderson ES; Rustum YM; Solomon JK
Cancer Treat Rep; 1982 Jan; 66(1):81-4. PubMed ID: 7053271
[TBL] [Abstract][Full Text] [Related]
39. Phase I--II study of 3-deazauridine in adults with acute leukemia.
Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(5-6):521-4. PubMed ID: 7237473
[TBL] [Abstract][Full Text] [Related]
40. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ; Momparler LF; Rivard GE; Momparler RL
Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
